LENSAR, Inc.

LNSR· Nasdaq· Surgical & Medical Instruments & Apparatus

Market cap
–
P/FCF
–
EV/Sales
–
FCF margin
-28.9%
ROIC, 5 yr avg
–
Revenue, 5 yr CAGR
+17.8%
We record prices for the companies we cover; LNSR is not one of them yet.

Company statistics

From the 10-Ks, computed in code · point at a figure for its formula

Profile · FY2025

Market cap
–
Enterprise value
–
Diluted shares
12.0M
Revenue
$51.7M
Free cash flow
-$14.9M
Owner earnings
-$18.1M

Valuation · FY2025

P/E
–
P/FCF
–
P/Owner earnings
–
EV/Sales
–
EV/FCF
–
P/B
–

Margins · FY2025

Gross
–
Operating
-47.6%
Net
-66.4%
Free cash flow
-28.9%
Owner earnings
-35.0%
Stock pay
6.1%

Returns

ROIC, FY2025
–
ROIC, 5 yr avg
–
ROE, FY2025
–
ROE, 5 yr avg
–

Growth (CAGR)

Revenue, 3 yr
20.6%
Revenue, 5 yr
17.8%
Revenue, 6 yr
11.9%
Diluted EPS, 3 yr
–
Diluted EPS, 5 yr
–
Diluted EPS, 6 yr
–
Free cash flow, 3 yr
–
Free cash flow, 5 yr
–
Free cash flow, 6 yr
–

Financial health · FY2025

Cash and investments
$18.0M
Total debt
–
Net cash
–
Debt/Equity
–
Debt/FCF
–

Shareholder returns · FY2025

Dividend yield
–
Payout ratio
–
Buyback yield
–
Shareholder yield
–
Share count, 5 yr
–

Financials: ten years from the 10-Ks

Reported numbers open their filing · computed ones show the formula · ˢ split-adjusted

Revenue

$51.7M

+11.9% a year over 6 years

FY2019: Revenue $26.3MFY2020: Revenue $22.8MFY2021: Revenue $29.5MFY2022: Revenue $29.4MFY2023: Revenue $35.7MFY2024: Revenue $46.0MFY2025: Revenue $51.7M
FY2019FY2025

Margins

Operating-47.6%Net-66.4%

FY2025

FY2019: Operating -48.3%, Net -55.6%FY2020: Operating -81.2%, Net -86.8%FY2021: Operating -66.6%, Net -66.5%FY2022: Operating -68.5%, Net -67.6%FY2023: Operating -34.2%, Net -40.3%FY2024: Operating -23.2%, Net -68.3%FY2025: Operating -47.6%, Net -66.4%
FY2019FY2025

Free cash flow and owner earnings

Free cash flow-$14.9MOwner earnings-$18.1M

FY2025

FY2019: Free cash flow -$13.0M, Owner earnings -$13.1MFY2020: Free cash flow -$14.2M, Owner earnings -$23.2MFY2021: Free cash flow -$9.3M, Owner earnings -$16.2MFY2022: Free cash flow -$15.0M, Owner earnings -$21.6MFY2023: Free cash flow -$9.9M, Owner earnings -$15.4MFY2024: Free cash flow -$2.4M, Owner earnings -$5.1MFY2025: Free cash flow -$14.9M, Owner earnings -$18.1M
FY2019FY2025

Diluted shares

12.0M

+27.6% over 6 years, net dilution

FY2019: Diluted shares –FY2020: Diluted shares –FY2021: Diluted shares 9.4MFY2022: Diluted shares 10.2MFY2023: Diluted shares 11.0MFY2024: Diluted shares 11.5MFY2025: Diluted shares 12.0M
FY2019FY2025

Every figure, year by year

Fiscal yearFY2019FY2020FY2021FY2022FY2023FY2024FY2025
The business
Revenue$26.3M$22.8M$29.5M$29.4M$35.7M$46.0M$51.7M
Revenue growth–-13.5%29.5%-0.2%21.3%28.7%12.4%
Gross margin–––––––
Operating margin-48.3%-81.2%-66.6%-68.5%-34.2%-23.2%-47.6%
Net income-$14.7M-$19.8M-$19.6M-$19.9M-$14.4M-$31.4M-$34.3M
Net margin-55.6%-86.8%-66.5%-67.6%-40.3%-68.3%-66.4%
Diluted EPS––$-2.09$-1.96$-1.31$-2.73$-2.87
Return on invested capital?–––––––
Cash
Operating cash flow-$12.6M-$13.8M-$9.0M-$14.9M-$9.7M-$2.3M-$14.8M
Capital expenditure$389.0K$366.0K$354.0K$115.0K$236.0K$156.0K$83.0K
Free cash flow-$13.0M-$14.2M-$9.3M-$15.0M-$9.9M-$2.4M-$14.9M
Stock-based compensation$102.0K$9.0M$6.9M$6.6M$5.5M$2.7M$3.1M
Owner earnings?-$13.1M-$23.2M-$16.2M-$21.6M-$15.4M-$5.1M-$18.1M
Free cash flow per share––$-0.99$-1.47$-0.90$-0.21$-1.25
Capital allocation
Dividends paid–––––––
Share repurchases–––––––
Diluted shares––9.4M10.2M11.0M11.5M12.0M
Share count change?–––8.4%8.0%5.0%3.8%
Balance sheet
Cash and equivalents$4.6M$40.6M$31.6M$14.7M$20.6M$16.3M$13.0M
Short-term investments––––$3.4M$6.2M$5.0M
Total debt–––––––
Net debt–––––––
Shareholders' equity-$30.6M$67.2M$54.9M$42.0M$33.4M$4.9M-$26.0M

Latest filings

All on EDGAR
2026-08-1310-QQuarterly report
2026-08-138-KEarnings release
2026-06-23DEF 14AProxy statement
2026-05-0810-QQuarterly report
2026-05-088-KEarnings release
2026-03-3110-KAnnual report
2026-03-318-KEarnings release
2025-11-0610-QQuarterly report
2025-11-068-KEarnings release
2025-11-05DEF 14AProxy statement

More from our coverage

All coverage